SCHEMBL8826186

SCHEMBL8826186

Nc1nc2ncnc-2cn1NCC1CC1

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ GPR39 O43194 1/20 0.32
▸ HRH4 Q9H3N8 1/20 0.31
▸ MAP4K4 O95819 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4440111 0.66 MAPT (0.46) —
SCHEMBL899400 0.64 ADORA2A (0.32) —
SCHEMBL12590817 0.56 RAB9A (0.48) HRH4MAP4K4
SCHEMBL7072307 0.55 — —
SCHEMBL10187127 0.54 HRH4 (0.56) GPR39HRH4
SCHEMBL7071992 0.54 PIK3CD (0.31) —
SCHEMBL13685177 0.54 PTGER4 (0.40) HRH4
SCHEMBL1774600 0.53 HRH4 (0.66) GPR39HRH4
SCHEMBL28182726 0.51 CDK5 (0.36) —
SCHEMBL22854663 0.51 PHF8 (0.45) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5663154-A VIRICIDES, HIV, HEPATITIS GLAXO WELLCOME INC. (US) 1997-09-02 — — US disclosed
EP-0625158-A1 THERAPEUTIC NUCLEOSIDES THE WELLCOME FOUNDATION LIMITED (GB) 1994-11-23 — — EP disclosed
WO-1993014103-A1 THERAPEUTIC NUCLEOSIDES THE WELLCOME FOUNDATION LIMITED (GB) 1993-07-22 — — WO disclosed
Send feedback